News about Market

Rubicon Research to Launch IPO on 9 October; Price Band Set at INR 461- INR 485 Per Share

Rubicon Research Limited has announced the launch of its initial public offering (IPO) of equity shares with a face value of ?1 each, opening on 9 October 2025. The Anchor Investor bidding date is set for 8 October 2025, while the offer will close on 13 October 2025.
<br />

Market | 07/10/2025 | By Darshana

Roche Pharma to Invest 1.5 Billion Swiss Francs in India Over Five Years, Boosting R&D and Access

The funding will be channelled into three critical areas, including research and development, expansion of core businesses, and work with initiatives like Ayushman Bharat to broaden access to innovative products for patients.

Market | 03/10/2025 | By Darshana

Virupaksha Organics Files Draft Papers with SEBI for INR 740 Crore IPO

Virupaksha Organics, an R&D-driven Indian pharmaceutical company specialising in active pharmaceutical ingredients (APIs) and intermediates, has filed draft papers with India’s capital markets regulator, SEBI, to raise INR 740 crore through an initial public offering (IPO).

Market | 01/10/2025 | By Darshana

Testo Saveris to Showcase Comprehensive Pharma Monitoring System at CPHI 2025

Instrumentation and measurement specialist Testo Saveris will present its fully automated and comprehensive monitoring system, testo Saveris 1 at CPHI 2025 in Frankfurt, taking place from 28–30 October.

Market | 01/10/2025 | By Dineshwori

India's Pharma Exports Set to Cross USD 30 Billion by Year-End: Dr Jitendra Singh

India’s pharma exports, currently valued at nearly USD 27.8 billion, are expected to cross USD 30 billion by the end of this year, Union Minister Dr. Jitendra Singh said.

Market | 01/10/2025 | By Dineshwori

Novo Nordisk to Launch Ozempic in India

The once-a-week injectable, Ozempic will complement Novo Nordisk’s existing oral Semaglutide for diabetes and recently approved WeGovy for obesity.

Market | 30/09/2025 | By Dineshwori

GlobalData's AI Tool Predicts Pharmaceutical Drug Approvals with 85 Percent Success Rate

GlobalData’s enhanced AI-powered Likelihood of Approval (LoA) model boosts its predictive power, providing probability of a drug receiving market authorisation.

Market | 29/09/2025 | By Dineshwori

Trump's 100 Percent Pharma Tariff to Have Twofold Impact on Indian Drugmakers

The proposed tariffs target only branded and patented medicines, leaving India’s generic exports largely unaffected. While companies making branded drugs for the US may face challenges, domestic generic producers could benefit from increased demand for affordable alternatives.

Market | 29/09/2025 | By Dineshwori |  127

Anbenitamab Set to Lead as First Bispecific mAb in China's HER2+ Gastric Cancer Market: GlobalData

China’s NMPA has accepted Alphamab Oncology’s NDA for KN026 (Anbenitamab), which could become the first bispecific mAb for HER2-positive gastric and GEJ cancer, according to GlobalData.

Market | 25/09/2025 | By Dineshwori

Vidal Health and SII Collaborate on HPV Vaccine Access

Vidal Health and Serum Institute of India (SII) have partnered to boost cervical cancer prevention, launching from 1 October 2025 a first-of-its-kind cashless platform for HPV vaccination—covering digital bookings, consent, and certification with zero paperwork.

Market | 24/09/2025 | By Dineshwori